Litalsa, Erle Robotics and Histocell: Basque companies that have received rounds in the Basque Country
03/07/2015
Diego Gutiérrez
Litalsa, Erle Robotics and Histocell: Basque companies that have received rounds in the Basque Country
In May, several Basque companies from different sectors received funding. Erle Robotics, a drone company, received €200,000 from 6 business angels. Histocell, located in Zamudio, has received €2.5 M to launch its new product and Realza has bought Litalsa, a leading independent supplier in the packaging lithography market.

 

Erle Robotics raises 200,000 euros in its funding round

The Alavesa drone company Erle Robotics, which stands out for its devices, developed with free software and hardware, has received a €200,000 funding round in which 6 business angels have participated, two Basque and four British.

 The company will use the funds to position its technology as a global pioneer and project its business internationally as it has just opened an office in Germany to strengthen its close relationship with the multinational. Bosch. Thanks to this foray into Germany, Erle Robotics has been selected by the German startup accelerator TechFounders to boost your business and develop new software for your device Erle Brain with new capabilities and sensors to enable new uses and applications.

"In addition, Elre Robotics intends to close another, larger round of financing in the second half of the year. Growth in this sector is essential to be able to compete. In Spain alone, the number of drone companies registered with AENA (Spanish airports and air navigation) has grown by 70 % so far in 2015. In addition, numerous internal companies have received million-dollar rounds in 2015, such as RD Robotics, which closed a $14M round in April" says Diego Gutierrez from Abra-Invest.

 Biopharmaceutical company Histocell receives round of funding

Biopharmaceuticals Histocell, located in the technology park of Zamudio, has closed a round 2.5m to bring its Reoxcare healing product to market, which is expected to be launched by the end of 2015. 

For the time being, the company has already reached agreements for the marketing of Reoxcare in different European and Asian markets, such as the one signed with the company Luqa Pharma for China, Hong Kong and Macao.

Histocell develops and commercialises medical devices and cell therapy medicines in the field of human health. In addition to the international launch of Reoxcare, the company plans to complete the development of three medical devices and to finalise the clinical phases I/IIa of two cell-based medicines in the five-year period 2015-2020.

 Realza buys Litalsa

Enhance Capital has bought a majority stake in the Basque company LitalsaAC Development, a leading independent supplier of lithography for packaging and mechanical closures, was in the hands of AC Development.

"For AC Desarrollo, the sale of Realza represents the first divestment of its AC Capital Premier II fund," says Diego Gutiérrez of AC Capital Premier II. Abra-Invest.

The purchase has been financed not only with equity but also with bank debt provided by Caixabank, Bankinter and Mutua.

With this investment, Realza expects to consolidate Litalsa's leadership in Spain and foster its international growth, accompanying existing customers.

 

If you are looking for financing in Abra -invest we can help you. Get in touch with us on +34.946024142

Other posts that may interest you

 biotech grows and finds alternative forms of finance

New funds for ICTs, Bio and internalisation (May)

Lastest news

Latest transactions in the Cybersecurity sector

El sector de la ciberseguridad ha sido testigo de una importante oleada de adquisiciones estratégicas en los últimos meses, a medida que las empresas tratan de ampliar sus capacidades y hacer frente a la creciente demanda de una sólida protección digital. Cinco...

Latest transactions in the Consumer Software sector

El sector del Consumer software ha experimentado recientemente una dinámica oleada de adquisiciones que pone de relieve su evolución hacia la mejora de la participación de los usuarios y la ampliación de los servicios digitales. Entre las operaciones más destacadas...

Do you want to sell or buy a company?

We are experts in M&A transactions in the technology sector.

Subscribe to our newsletter

Request for information

If you want to buy or sell a company, or need more information about our services, do not hesitate to contact us through the form.

Or if you prefer, call us at:

+34 946 42 41 42